Skip to main content
. Author manuscript; available in PMC: 2016 Nov 8.
Published in final edited form as: Osteoporos Int. 2010 Aug 4;22(3):789–796. doi: 10.1007/s00198-010-1359-2

Fig. 3.

Fig. 3

Percentage of women aged 50 and over with BMD≤−2.5 on therapy with any osteoporosis medication (calcitonin, SERM, HT, bisphosphonate) over each of the 10 years in the Canadian Multicentre Osteoporosis Study (CaMOS)